Y
YourChoice Therapeutics
Birth Control Designed for Men
About YourChoice Therapeutics
YourChoice Therapeutics is a pioneering company in the contraceptive market, focusing on the development of hormone-free birth control options for both men and women. The company targets individuals and families seeking safe, effective, and reversible contraceptive solutions without the adverse side effects commonly associated with traditional methods. Operating within the healthcare and pharmaceutical sectors, YourChoice Therapeutics leverages over a decade of research conducted at the University of California, Berkeley. Their innovative approach involves the use of small molecules to block specific targets on sperm, preventing fertilization. The business model revolves around bringing these groundbreaking products to market, generating revenue through product sales and potentially licensing agreements. By addressing a significant gap in the contraceptive market, YourChoice Therapeutics aims to improve family planning and reduce poverty levels associated with unplanned pregnancies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Berkeley, United States
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 86.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Sustainable Development Goals, Mentech, Tech for Patients, Biotech and Pharma, YC W19, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Mar 2024 | $500K | — | Male Contraceptive Initiative | ↗ |
| SERIES A✓Equity / VC | Jul 2022 | $15M | $60M | Knollwood · Future Ventures · Refactor Capital · R-H Capital Partners | ↗ |
Growth signals
Latest recorded traffic for YourChoice Therapeutics is 1.8K monthly website visits, up 153.5% over the last three months. YourChoice Therapeutics's team grew 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Y Combinator
Kingsley Advani- EPErik Peterson
Male Contraceptive Initiative
Series A6 investors entered at this stage
Berkeley SkyDeck Accelerator
Future Ventures- KNKnollwood
Refactor Capital- RPR-H Capital Partners
North South Ventures
Other known investors11 additional known investors
CITRIS Foundry
University of California, Berkeley- BVBlue Bear Ventures
California Life Sciences
Civilization Ventures
QB3
RHIA Ventures
SchindlerAM Ventures
StartOut Growth Lab
Transitions First
Worldera
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about YourChoice Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See YourChoice Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.